As of 2025-07-12, the Intrinsic Value of Anavex Life Sciences Corp (AVXL) is -2.76 USD. This Anavex valuation is based on the model Peter Lynch Fair Value. With the current market price of 11.11 USD, the upside of Anavex Life Sciences Corp is -124.85%.
Based on its market price of 11.11 USD and our intrinsic valuation, Anavex Life Sciences Corp (AVXL) is overvalued by 124.85%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.76 - -2.76 | -2.76 | -124.85% |
| P/E | (7.84) - (14.80) | (11.97) | -207.7% |
| DDM - Stable | (3.58) - (9.37) | (6.48) | -158.3% |
| DDM - Multi | (0.96) - (1.98) | (1.29) | -111.6% |
| Market Cap (mil) | 948.46 |
| Beta | 1.26 |
| Outstanding shares (mil) | 85.37 |
| Enterprise Value (mil) | 832.69 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.05% |
| Cost of Debt | 5.00% |
| WACC | 8.52% |